TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IPSC

Century Therapeutics Inc

Healthcare · Biotechnology

1.70$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Century Therapeutics Inc (IPSC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.9% of the shares are freely tradable; institutional investors hold 82.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 82.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 8.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 55.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 16.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 181Mio.

Largest Shareholders

Institutions

Institutions IPSC
Name Stake (%) Shares Change (%) Date
RA Capital Management, LLC 9.81 17,754,430 +0.0 03/31/2026
TCG Crossover Management, LLC 9.81 17,754,430 +0.0 06/30/2026
Versant Venture Management LLC 6.72 12,166,109 +0.0 06/30/2026
Deep Track Capital, LP 5.23 9,462,645 -0.3 06/30/2026
VR Adviser, LLC 4.80 8,695,652 +0.0 03/31/2026
COMMODORE CAPITAL LP 4.80 8,695,652 +0.0 03/31/2026
RTW INVESTMENTS, LLC 4.80 8,695,652 +0.0 03/31/2026
Point72 Asset Management, L.P. 3.29 5,964,678 +0.1 03/31/2026
Vanguard Capital Management, LLC 3.14 5,686,204 +0.0 03/31/2026
Balyasny Asset Management LLC 2.77 5,017,733 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings IPSC
Person Role Shares Value As of Type
Pfeiffenberger Brent President and CEO 3,633,839 6,177,526 $ Sep 11, 2026 direct
Russotti Gregory See Remarks 509,198 865,637 $ Sep 14, 2026 direct
Carr Douglas SVP Finance & Operations 502,907 854,942 $ Sep 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 14, 2026 Russotti Gregory See Remarks Sell 2,587 1.93 4,993
Sep 14, 2026 Carr Douglas SVP Finance & Operations Sell 1,658 1.93 3,200
Sep 11, 2026 Pfeiffenberger Brent President and CEO Other 13,850 1.94 26,869
Sep 8, 2026 Russotti Gregory See Remarks Sell 534 2.05 1,095
Sep 8, 2026 Carr Douglas SVP Finance & Operations Sell 254 2.05 521
Sep 4, 2026 Pfeiffenberger Brent President and CEO Other 463 2.11 977
Aug 14, 2026 Pfeiffenberger Brent President and CEO Other 31,172 1.92 59,850

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?